Cargando…
Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin.
Weekly treatments with doxorubicin encapsulated in long circulating, sterically stabilised liposomes (DOX-SL) reduced the incidence of metastases from primary mammary carcinoma from 24 of 47 untreated mice to 3 of 23 treated mice. Toxic side-effects were limited to minor, transient weight losses.
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033931/ https://www.ncbi.nlm.nih.gov/pubmed/7577449 |
_version_ | 1782136945585946624 |
---|---|
author | Vaage, J. Donovan, D. Loftus, T. Working, P. |
author_facet | Vaage, J. Donovan, D. Loftus, T. Working, P. |
author_sort | Vaage, J. |
collection | PubMed |
description | Weekly treatments with doxorubicin encapsulated in long circulating, sterically stabilised liposomes (DOX-SL) reduced the incidence of metastases from primary mammary carcinoma from 24 of 47 untreated mice to 3 of 23 treated mice. Toxic side-effects were limited to minor, transient weight losses. |
format | Text |
id | pubmed-2033931 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1995 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20339312009-09-10 Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin. Vaage, J. Donovan, D. Loftus, T. Working, P. Br J Cancer Research Article Weekly treatments with doxorubicin encapsulated in long circulating, sterically stabilised liposomes (DOX-SL) reduced the incidence of metastases from primary mammary carcinoma from 24 of 47 untreated mice to 3 of 23 treated mice. Toxic side-effects were limited to minor, transient weight losses. Nature Publishing Group 1995-11 /pmc/articles/PMC2033931/ /pubmed/7577449 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Vaage, J. Donovan, D. Loftus, T. Working, P. Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin. |
title | Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin. |
title_full | Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin. |
title_fullStr | Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin. |
title_full_unstemmed | Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin. |
title_short | Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin. |
title_sort | prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033931/ https://www.ncbi.nlm.nih.gov/pubmed/7577449 |
work_keys_str_mv | AT vaagej preventionofmetastasisfrommousemammarycarcinomaswithliposomescarryingdoxorubicin AT donovand preventionofmetastasisfrommousemammarycarcinomaswithliposomescarryingdoxorubicin AT loftust preventionofmetastasisfrommousemammarycarcinomaswithliposomescarryingdoxorubicin AT workingp preventionofmetastasisfrommousemammarycarcinomaswithliposomescarryingdoxorubicin |